表紙
市場調查報告書
商品編碼
1062843

全球神經血管設備市場(2022-2028 年):市場預測(按產品、工藝、應用、最終用戶)、區域前景、增長潛力、COVID-19 的影響、市場份額

Neurovascular Devices Market Size By Product, By Process, By Therapeutic Applications, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028

出版日期: | 出版商: Global Market Insights Inc. | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

由於全球神經系統疾病患病率激增,預計到 2028 年神經血管設備市場將顯著增長。

快速增加的疾病負擔進一步要求開發更有效的神經血管設備,這將是未來幾年行業前景的最突出驅動力。

按產品劃分,氣球系統行業預計在預測期內將以約 6% 的複合年增長率顯著增長。這是由於技術進步使產品對患者更安全、更有效。從工藝上看,2021 年支架行業將達到 4.53 億美元以上,並且由於治療神經血管疾病的產品需求增加,預計未來將穩定增長。

本報告探討了全球神經血管設備市場、市場定義和概述、冠狀病毒病 (COVID-19) 和其他市場影響因素分析、監管和報銷環境以及市場。它總結了規模變化/預測、細分產品/工藝/應用/最終用戶/地區/主要國家、競爭環境、主要公司概況等各種類別。

目錄

第一章調查方法

第2章執行摘要

第三章神經血管器械行業的思考

  • 行業分類
  • 產業情況
  • 行業影響因素
    • 生長因子
    • 潛在風險和挑戰
  • 增長潛力
  • COVID-19:影響分析
  • 波特分析
  • 監管與贖回情況
  • 競爭形勢
  • PESTEL 分析

第 4 章神經血管設備市場:按產品分類

  • 主要趨勢
  • 栓塞線圈
  • 頸動脈支架
  • 顱內支架
  • 導管
  • 栓塞保護裝置
  • 分流器
  • 神經取栓裝置
  • 囊內裝置
  • 氣球系統
  • 支架取回器
  • 導絲
  • 其他

第 5 章神經血管設備市場:按流程

  • 主要趨勢
  • 神經血栓切除術
  • 腦血管造影技術
  • 頸動脈內膜切除術 (CEA)
  • 支架置入
  • 顯微手術夾取
  • 線圈栓塞
  • 流模版
  • 其他

第 6 章神經血管器械市場:按應用分類

  • 主要趨勢
  • 腦動脈瘤
  • 狹窄
  • 缺血性中風
  • 其他

第 7 章神經血管設備市場:按最終用戶分類

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第 8 章神經血管器械市場:按地區劃分

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 9 章公司簡介

  • 策略儀表板
  • Asahi Intecc CO., LTD.
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corp.
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker
  • Terumo Corporation
目錄
Product Code: 794

The neurovascular devices market is pegged to register considerable gains by 2028, driven by the rapidly growing prevalence of neurological disorders across the globe. The fast growing disease load is further calling for the development of more effective neurovascular devices, which will most notably drive the industry outlook over the forthcoming yeas.

Neurological disorders, also known as NDs, are heterogeneous diseases which affect the body's peripheral, autonomic, as well as central nervous system. Some of the non-communicable NDs include ailments such as multiple sclerosis, non-migraine headaches, migraines, Alzheimer's disease as well as other dementias, epilepsy, Parkinson's disease, and other neurological disorders.

Lately, the overall burden of disability and deaths caused by NDs is increasingly being recognized by global healthcare organization as an international public health challenge. According to the Pan American Health Organization, the burden of these diseases is set to grow tremendously over the next couple of decades, primarily as an outcome of the population aging phenomenon.

As per the most recent United Nations report, up to 1 billion people, or approximately one in six of the globe's population, suffers from neurological disorders, with approximately 6.8 million succumbing to the maladies each year.

The overall neurovascular devices market share is outlined on the basis of different segments such as product, process, therapeutic applications, region, and end-use.

With respect to product the market is further classified in terms of carotid stents, embolic coils, catheters, intracranial stents, flow diverters, embolic protection devices, intrasaccular devices, neurothrombectomy devices, stent retrievers, balloon systems, guidewires, and others. Among these, the balloon systems segment is forecast to register tremendous gains, of around 6% CAGR through the analysis timeframe. This is due to the increasing number of technological advancements in the product anatomy, which is making it safer and more effective for patients.

Based on process, the industry is classified into cerebral angiography, neurothrombectomy, stenting, carotid endarterectomy, microsurgical clipping, flow diversion, coiling, and others. In 2021, the stenting segment was valued at more than USD 453 million. The segment is slated to grow at a steady pace due to the growing demand for the product in treating neurovascular diseases.

With regards to therapeutic application, the stenosis segment is slated to see notable impetus for growth. In fact, the segment is pegged to witness more than 6% CAGR over the forecast period owing to increasing prevalence of the disease.

Ambulatory surgical centers would be emerging as the most distinguished end-use segment having held a market valuation around USD 1 billion in 2021. The growth is attributed to low-cost treatment offered at ambulatory surgical centers.

The Latin America neurovascular devices market is expected to witness a CAGR of over 4.5% through the forecast period owing to the developing healthcare and medical care infrastructure of the region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Neurovascular devices industry 360 degree synopsis, 2017 - 2028
  • 2.2 Business trends
  • 2.3 Product trends
  • 2.4 Process trends
  • 2.5 Therapeutic application trends
  • 2.6 End-use trends
  • 2.7 Regional trends

Chapter 3 Neurovascular Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
      • 3.3.1.2 Rising demand for minimally invasive surgical procedures
      • 3.3.1.3 Technological advancement in neurovascular treatments
      • 3.3.1.4 Government initiatives to modernize healthcare infrastructure across the globe
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Need for designing more effective and low-cost treatments
      • 3.3.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By process
    • 3.4.3 By therapeutic application
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Regulatory and reimbursement landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
    • 3.7.3 China
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 Neurovascular Devices Market, By Product

  • 4.1 Key segment trends
  • 4.2 Embolic Coils
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.3 Carotid Stents
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.4 Intracranial Stents
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.4.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.5 Catheters
    • 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.5.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.6 Embolic Protection Devices
    • 4.6.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.6.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.7 Flow Diverters
    • 4.7.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.7.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.8 Neurothrombectomy Devices
    • 4.8.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.8.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.9 Intrasaccular Devices
    • 4.9.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.9.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.10 Balloon Systems
    • 4.10.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.10.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.11 Stent Retrievers
    • 4.11.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.11.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.12 Guidewires
    • 4.12.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.12.2 Market size, by region, 2017 - 2028 (000' Units)
  • 4.13 Others
    • 4.13.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.13.2 Market size, by region, 2017 - 2028 (000' Units)

Chapter 5 Neurovascular Devices Market, By Process

  • 5.1 Key segment trends
  • 5.2 Neurothrombectomy Procedure
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Cerebral Angiography Technique
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Carotid Endarterectomy (CEA)
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Stenting
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.6 Microsurgical Clipping
    • 5.6.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.7 Coiling
    • 5.7.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.8 Flow Diversion
    • 5.8.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.9 Others
    • 5.9.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Neurovascular Devices Market, By Therapeutic Application

  • 6.1 Key segment trends
  • 6.2 Brain Aneurysm
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Stenosis
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Ischemic Strokes
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Neurovascular Devices Market, By End-use

  • 7.1 Key segment trends
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.4 Clinics
    • 7.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.5 Others
    • 7.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 8 Neurovascular Devices Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.2.2 Market size, by country, 2017 - 2028 (000' Units)
    • 8.2.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.2.4 Market size, by product, 2017 - 2028 (000' Units)
    • 8.2.5 Market size, by process, 2017 - 2028 (USD Million)
    • 8.2.6 Market size, by therapeutic application, 2017 - 2028 (USD Million)
    • 8.2.7 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.8 U.S.
      • 8.2.8.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.2.8.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.2.8.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.2.8.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.2.8.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.9 Canada
      • 8.2.9.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.2.9.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.2.9.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.2.9.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.2.9.5 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.3.2 Market size, by country, 2017 - 2028 (000' Units)
    • 8.3.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.3.4 Market size, by product, 2017 - 2028 (000' Units)
    • 8.3.5 Market size, by process, 2017 - 2028 (USD Million)
    • 8.3.6 Market size, by therapeutic application, 2017 - 2028 (USD Million)
    • 8.3.7 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.8 Germany
      • 8.3.8.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.8.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.8.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.8.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.8.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.9 France
      • 8.3.9.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.9.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.9.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.9.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.9.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.10 UK
      • 8.3.10.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.10.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.10.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.10.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.10.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.11 Italy
      • 8.3.11.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.11.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.11.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.11.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.11.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.12 Spain
      • 8.3.12.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.12.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.12.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.12.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.12.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.13 Russia
      • 8.3.13.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.13.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.13.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.13.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.13.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.14 Turkey
      • 8.3.14.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.14.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.14.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.14.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.14.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.15 Netherlands
      • 8.3.15.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.15.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.15.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.15.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.15.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.16 Belgium
      • 8.3.16.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.16.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.16.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.16.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.16.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.17 Austria
      • 8.3.17.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.17.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.17.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.17.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.17.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.18 Switzerland
      • 8.3.18.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.18.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.18.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.18.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.18.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.19 Poland
      • 8.3.19.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.19.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.19.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.19.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.19.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.20 Czech Republic
      • 8.3.20.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.20.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.20.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.20.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.20.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.21 Hungary
      • 8.3.21.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.21.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.21.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.21.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.21.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.22 Portugal
      • 8.3.22.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.22.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.22.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.22.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.22.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.23 Greece
      • 8.3.23.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.23.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.23.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.23.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.23.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.24 Romania
      • 8.3.24.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.24.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.24.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.24.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.24.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.25 Bulgaria
      • 8.3.25.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.25.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.25.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.25.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.25.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.26 Denmark
      • 8.3.26.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.26.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.26.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.26.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.26.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.27 Sweden
      • 8.3.27.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.27.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.27.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.27.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.27.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.28 Norway
      • 8.3.28.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.28.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.28.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.28.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.28.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.29 Finland
      • 8.3.29.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.3.29.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.3.29.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.3.29.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.3.29.5 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.4.2 Market size, by country, 2017 - 2028 (000' Units)
    • 8.4.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.4.4 Market size, by product, 2017 - 2028 (000' Units)
    • 8.4.5 Market size, by process, 2017 - 2028 (USD Million)
    • 8.4.6 Market size, by therapeutic application, 2017 - 2028 (USD Million)
    • 8.4.7 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.8 Japan
      • 8.4.8.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.8.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.8.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.8.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.8.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.9 China
      • 8.4.9.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.9.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.9.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.9.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.9.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.10 India
      • 8.4.10.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.10.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.10.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.10.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.10.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.11 Australia
      • 8.4.11.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.11.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.11.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.11.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.11.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.12 Korea
      • 8.4.12.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.12.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.12.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.12.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.12.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.13 Singapore
      • 8.4.13.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.13.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.13.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.13.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.13.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.14 Hong Kong
      • 8.4.14.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.14.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.14.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.14.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.14.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.15 Taiwan
      • 8.4.15.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.15.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.15.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.15.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.15.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.16 Indonesia
      • 8.4.16.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.16.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.16.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.16.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.16.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.17 Cambodia
      • 8.4.17.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.17.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.17.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.17.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.17.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.18 Philippines
      • 8.4.18.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.18.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.18.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.18.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.18.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.19 Vietnam
      • 8.4.19.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.19.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.19.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.19.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.19.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.20 Malaysia
      • 8.4.20.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.20.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.20.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.20.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.20.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.21 Thailand
      • 8.4.21.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.4.21.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.4.21.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.4.21.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.4.21.5 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.5.2 Market size, by country, 2017 - 2028 (000' Units)
    • 8.5.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.5.4 Market size, by product, 2017 - 2028 (000' Units)
    • 8.5.5 Market size, by process, 2017 - 2028 (USD Million)
    • 8.5.6 Market size, by therapeutic application, 2017 - 2028 (USD Million)
    • 8.5.7 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.8 Brazil
      • 8.5.8.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.5.8.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.5.8.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.5.8.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.5.8.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.9 Mexico
      • 8.5.9.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.5.9.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.5.9.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.5.9.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.5.9.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.10 Argentina
      • 8.5.10.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.5.10.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.5.10.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.5.10.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.5.10.5 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.6 MEA
    • 8.6.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.6.2 Market size, by country, 2017 - 2028 (000' Units)
    • 8.6.3 Market size, by product, 2017 - 2028 (USD Million)
    • 8.6.4 Market size, by product, 2017 - 2028 (000' Units)
    • 8.6.5 Market size, by process, 2017 - 2028 (USD Million)
    • 8.6.6 Market size, by therapeutic application, 2017 - 2028 (USD Million)
    • 8.6.7 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.8 Saudi Arabia
      • 8.6.8.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.6.8.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.6.8.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.6.8.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.6.8.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.9 UAE
      • 8.6.9.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.6.9.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.6.9.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.6.9.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.6.9.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.10 South Africa
      • 8.6.10.1 Market size, by product, 2017 - 2028 (USD Million)
      • 8.6.10.2 Market size, by product, 2017 - 2028 (000' Units)
      • 8.6.10.3 Market size, by process, 2017 - 2028 (USD Million)
      • 8.6.10.4 Market size, by therapeutic application, 2017 - 2028 (USD Million)
      • 8.6.10.5 Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Strategy dashboard, 2021
  • 9.2 Asahi Intecc CO., LTD.
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Integer Holdings Corporation
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Johnson & Johnson Services, Inc.
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Kaneka Medix Corp.
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 SWOT analysis
  • 9.6 LivaNova PLC
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Medtronic
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 MicroPort Scientific Corporation
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Penumbra, Inc.
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Stryker
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Terumo Corporation
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis

Data Tables

  • TABLE 1 Neurovascular devices industry 360 degree synopsis, 2017 - 2028
  • TABLE 2 Global neurovascular devices market, 2017 - 2028 (USD Million)
  • TABLE 3 Global neurovascular devices market, 2017 - 2028 (000' Units)
  • TABLE 4 Global neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 5 Global neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 6 Global neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 7 Global neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 8 Global neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 9 Global neurovascular devices market, by region, 2017 - 2028 (USD Million)
  • TABLE 10 Global neurovascular devices market, by region, 2017 - 2028 (000' Units)
  • TABLE 11 Industry impact forces
  • TABLE 12 Embolic coils market, by region, 2017 - 2028 (USD Million)
  • TABLE 13 Embolic coils market, by region, 2017 - 2028 (000' Units)
  • TABLE 14 Carotid stents market, by region, 2017 - 2028 (USD Million)
  • TABLE 15 Carotid stents market, by region, 2017 - 2028 (000' Units)
  • TABLE 16 Intracranial stents market, by region, 2017 - 2028 (USD Million)
  • TABLE 17 Intracranial stents market, by region, 2017 - 2028 (000' Units)
  • TABLE 18 Neurovascular thrombectomy devices market, by region, 2017 - 2028 (USD Million)
  • TABLE 19 Neurovascular thrombectomy devices market, by region, 2017 - 2028 (000' Units)
  • TABLE 20 Embolic protection devices market, by region, 2017 - 2028 (USD Million)
  • TABLE 21 Embolic protection devices market, by region, 2017 - 2028 (000' Units)
  • TABLE 22 Flow diverters market, by region, 2017 - 2028 (USD Million)
  • TABLE 23 Flow diverters market, by region, 2017 - 2028 (000' Units)
  • TABLE 24 Intrasaccular devices market, by region, 2017 - 2028 (USD Million)
  • TABLE 25 Intrasaccular devices market, by region, 2017 - 2028 (000' Units)
  • TABLE 26 Liquid embolic coils market, by region, 2017 - 2028 (USD Million)
  • TABLE 27 Liquid embolic coils market, by region, 2017 - 2028 (000' Units)
  • TABLE 28 Balloon catheters market, by region, 2017 - 2028 (USD Million)
  • TABLE 29 Balloon catheters market, by region, 2017 - 2028 (000' Units)
  • TABLE 30 Stent retrievers' market, by region, 2017 - 2028 (USD Million)
  • TABLE 31 Stent retrievers' market, by region, 2017 - 2028 (000' Units)
  • TABLE 32 Guidewires market, by region, 2017 -2028 (USD Million)
  • TABLE 33 Guidewires market, by region, 2017 -2028 (000' Units)
  • TABLE 34 Others market, by region, 2017 -2028 (USD Million)
  • TABLE 35 Others market, by region, 2017 -2028 (000' Units)
  • TABLE 36 Neurothrombectomy market, by region, 2017 - 2028 (USD Million)
  • TABLE 37 Cerebral angiography market, by region, 2017 - 2028 (USD Million)
  • TABLE 38 Carotid endarterectomy market, by region, 2017 - 2028 (USD Million)
  • TABLE 39 Stenting market, by region, 2017 - 2028 (USD Million)
  • TABLE 40 Coiling market, by region, 2017 - 2028 (USD Million)
  • TABLE 41 Microsurgical clipping market, by region, 2017 - 2028 (USD Million)
  • TABLE 42 Flow diversion market, by region, 2017 - 2028 (USD Million)
  • TABLE 43 Others market, by region, 2017 -2028 (USD Million)
  • TABLE 44 Brain aneurysm market, by region, 2017 -2028 (USD Million)
  • TABLE 45 Stenosis market, by region, 2017 - 2028 (USD Million)
  • TABLE 46 Ischemic strokes market, by region, 2017 - 2028 (USD Million)
  • TABLE 47 Others market, by region, 2017 - 2028 (USD Million)
  • TABLE 48 Hospitals market, by region, 2017 - 2028 (USD Million)
  • TABLE 49 Ambulatory surgical units' market, by region, 2017 - 2028 (USD Million)
  • TABLE 50 Clinics market, by region, 2017 - 2028 (USD Million)
  • TABLE 51 Others market, by region, 2017 - 2028 (USD Million)
  • TABLE 52 North America neurovascular devices market, by country, 2017 - 2028 (USD Million)
  • TABLE 53 North America neurovascular devices market, by country, 2017 - 2028 (000' Units)
  • TABLE 54 North America neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 55 North America neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 56 North America neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 57 North America neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 58 North America neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 59 U.S. neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 60 U.S. neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 61 U.S. neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 62 U.S. neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 63 U.S. neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 64 Canada neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 65 Canada neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 66 Canada neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 67 Canada neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 68 Canada neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 69 Europe neurovascular devices market, by country, 2017 - 2028 (USD Million)
  • TABLE 70 Europe neurovascular devices market, by country, 2017 - 2028 (000' Units)
  • TABLE 71 Europe neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 72 Europe neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 73 Europe neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 74 Europe neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 75 Europe neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 76 Germany neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 77 Germany neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 78 Germany neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 79 Germany neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 80 Germany neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 81 France neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 82 France neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 83 France neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 84 France neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 85 France neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 86 UK neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 87 UK neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 88 UK neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 89 UK neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 90 UK neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 91 Italy neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 92 Italy neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 93 Italy neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 94 Italy neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 95 Italy neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 96 Spain neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 97 Spain neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 98 Spain neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 99 Spain neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 100 Spain neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 101 Russia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 102 Russia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 103 Russia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 104 Russia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 105 Russia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 106 Turkey neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 107 Turkey neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 108 Turkey neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 109 Turkey neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 110 Turkey neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 111 Netherlands neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 112 Netherlands neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 113 Netherlands neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 114 Netherlands neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 115 Netherlands neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 116 Belgium neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 117 Belgium neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 118 Belgium neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 119 Belgium neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 120 Belgium neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 121 Belgium neurovascular devices market, by end-use, 2017 - 2028 (000' Units)
  • TABLE 122 Austria neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 123 Austria neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 124 Austria neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 125 Austria neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 126 Austria neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 127 Switzerland neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 128 Switzerland neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 129 Switzerland neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 130 Switzerland neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 131 Switzerland neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 132 Poland neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 133 Poland neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 134 Poland neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 135 Poland neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 136 Poland neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 137 Czech Republic neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 138 Czech Republic neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 139 Czech Republic neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 140 Czech Republic neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 141 Czech Republic neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 142 Hungary neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 143 Hungary neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 144 Hungary neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 145 Hungary neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 146 Hungary neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 147 Portugal neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 148 Portugal neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 149 Portugal neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 150 Portugal neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 151 Portugal neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 152 Greece neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 153 Greece neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 154 Greece neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 155 Greece neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 156 Greece neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 157 Romania neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 158 Romania neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 159 Romania neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 160 Romania neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 161 Romania neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 162 Bulgaria neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 163 Bulgaria neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 164 Bulgaria neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 165 Bulgaria neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 166 Bulgaria neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 167 Denmark neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 168 Denmark neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 169 Denmark neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 170 Denmark neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 171 Denmark neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 172 Sweden neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 173 Sweden neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 174 Sweden neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 175 Sweden neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 176 Sweden neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 177 Norway neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 178 Norway neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 179 Norway neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 180 Norway neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 181 Norway neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 182 Finland neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 183 Finland neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 184 Finland neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 185 Finland neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 186 Finland neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 187 Asia Pacific neurovascular devices market, by country, 2017 - 2028 (USD Million)
  • TABLE 188 Asia Pacific neurovascular devices market, by country, 2017 - 2028 (000' Units)
  • TABLE 189 Asia Pacific neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 190 Asia Pacific neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 191 Asia Pacific neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 192 Asia Pacific neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 193 Asia Pacific neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 194 Japan neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 195 Japan neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 196 Japan neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 197 Japan neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 198 Japan neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 199 Japan neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 200 China neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 201 China neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 202 China neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 203 China neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 204 China neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 205 India neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 206 India neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 207 India neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 208 India neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 209 India neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 210 Australia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 211 Australia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 212 Australia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 213 Australia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 214 Australia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 215 South Korea neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 216 South Korea neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 217 South Korea neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 218 South Korea neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 219 South Korea neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 220 Singapore neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 221 Singapore neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 222 Singapore neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 223 Singapore neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 224 Singapore neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 225 Hong Kong neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 226 Hong Kong neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 227 Hong Kong neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 228 Hong Kong neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 229 Hong Kong neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 230 Taiwan neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 231 Taiwan neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 232 Taiwan neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 233 Taiwan neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 234 Taiwan neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 235 Indonesia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 236 Indonesia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 237 Indonesia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 238 Indonesia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 239 Indonesia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 240 Cambodia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 241 Cambodia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 242 Cambodia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 243 Cambodia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 244 Cambodia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 245 Philippines neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 246 Philippines neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 247 Philippines neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 248 Philippines neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 249 Philippines neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 250 Vietnam neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 251 Vietnam neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 252 Vietnam neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 253 Vietnam neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 254 Vietnam neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 255 Malaysia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 256 Malaysia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 257 Malaysia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 258 Malaysia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 259 Malaysia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 260 Thailand neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 261 Thailand neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 262 Thailand neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 263 Thailand neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 264 Thailand neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 265 Latin America neurovascular devices market, by country, 2017 - 2028 (USD Million)
  • TABLE 266 Latin America neurovascular devices market, by country, 2017 - 2028 (000' Units)
  • TABLE 267 Latin America neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 268 Latin America neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 269 Latin America neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 270 Latin America neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 271 Latin America neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 272 Brazil neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 273 Brazil neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 274 Brazil neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 275 Brazil neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 276 Brazil neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 277 Mexico neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 278 Mexico neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 279 Mexico neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 280 Mexico neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 281 Mexico neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 282 Argentina neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 283 Argentina neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 284 Argentina neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 285 Argentina neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 286 Argentina neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 287 MEA neurovascular devices market, by country, 2017 - 2028 (USD Million)
  • TABLE 288 MEA neurovascular devices market, by country, 2017 - 2028 (000' Units)
  • TABLE 289 MEA neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 290 MEA neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 291 MEA neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 292 MEA neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 293 MEA neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 294 Saudi Arabia neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 295 Saudi Arabia neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 296 Saudi Arabia neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 297 Saudi Arabia neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 298 Saudi Arabia neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 299 UAE neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 300 UAE neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 301 UAE neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 302 UAE neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 303 UAE neurovascular devices market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 304 South Africa neurovascular devices market, by product, 2017 - 2028 (USD Million)
  • TABLE 305 South Africa neurovascular devices market, by product, 2017 - 2028 (000' Units)
  • TABLE 306 South Africa neurovascular devices market, by process, 2017 - 2028 (USD Million)
  • TABLE 307 South Africa neurovascular devices market, by therapeutic application, 2017 - 2028 (USD Million)
  • TABLE 308 South Africa neurovascular devices market, by end-use, 2017 - 2028 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global neurovascular devices market size, 2017 - 2028 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Growth potential analysis, by process
  • FIG. 5 Growth potential analysis, by therapeutic application
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Company matrix analysis
  • FIG. 8 Porter's analysis
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by product
  • FIG. 11 Key segment trends, by process
  • FIG. 12 Key segment trends, by therapeutic application
  • FIG. 13 Key segment trends, by end-use
  • FIG. 14 Key regional trends
  • FIG. 15 Strategy dashboard, 2021